Ledger.Open graph →
SEC Form D · filed May 1, 2014

ProNAi Therapeutics Inc

Offering
$59.5M
Sold
$59.5M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
Plymouth, MI
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (14)

Albert Cha · DUBLIN, CADirectorPeter Thompson · Seattle, WADirectorMustafa J. Al Lawati · DUBAI, C0DirectorRichard Messmann · Plymouth, MIExecAlvin Vitangcol · Plymouth, MIDirectorDonald Parfet · Plymouth, MIDirectorMina Sooch · Plymouth, MIExecPeter Thompson · New York, NYDirectorJames Topper · Seattle, WADirectorWendi Rodrigueza · Plymouth, MIExecAli J. Al Lawati · DUBAI, C0ExecJames Topper · Newton, MADirectorRoderick M. Forrest · Hamilton, BermudaExecWindham Capital Management LLC · Boston, MADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗